Viewing Study NCT00001059


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-01-04 @ 9:20 AM
Study NCT ID: NCT00001059
Status: COMPLETED
Last Update Posted: 2012-04-17
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: ACTG 286
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View